Latest Genetic testing Stories
CENTENNIAL, Colo., March 21, 2012 /PRNewswire/ -- LABS, Inc., a global, full-service testing laboratory with more than 30 years of expertise in regulated testing for human organs, cells, tissues and implantable biologic products and devices, this month launches a group of new laboratory tests suitable for screening complex biologic products. These new offerings will allow the company to provide innovative solutions with faster turnaround times to meet the needs of existing and...
Specialists agree: Many of the incidental findings discovered during genetic testing should be reported to ordering physician With whole-genome and whole-exome sequencing declining in price and improving in accuracy, these technologies are rapidly being integrated into clinical medicine. However, one of the most difficult obstacles to this integration is the uncertainty about searching for and reporting genetic results that are "incidental" or unrelated to the reasons the test was...
American Heart Association meeting report Watching too much TV can worsen your genetic tendency towards obesity, but you can cut the effect in half by walking briskly for an hour a day, researchers report at the American Heart Association's Epidemiology and Prevention/Nutrition, Physical Activity and Metabolism 2012 Scientific Sessions. "While previous studies have looked at how physical activity affects genetic predispositions, this is the first study that directly looked at the effect...
SAN DIEGO, Feb. 27, 2012 /PRNewswire/ -- Trovagene, Inc. (Pink Sheets: TROV.PK), a developer of trans-renal molecular diagnostics, today announced that it has hired Leomics Associates, Inc. to expand its business development activities and monetize the company's high value intellectual property estate. "Trovagene owns a significant portfolio of molecular diagnostic intellectual property with relevance for a broad array of clinical applications. While the company will focus its...
While both tests look for the same thing, chromosomal microarray finds more, says New York-Presbyterian/Columbia researcher who led nationwide study A nationwide, federally funded study has found that testing a developing fetus' DNA through chromosomal microarray (CMA) provides more information about potential disorders than does the standard method of prenatal testing, which is to visually examine the chromosomes (karyotyping). The results of the 4,000-plus-participant clinical study are...
SAN JOSE, Calif., Feb. 6, 2012 /PRNewswire/ -- Aria Diagnostics, a molecular diagnostics company, today announced that its new prenatal test has been named the Harmony Prenatal Test(TM). The test is a directed non-invasive approach to cell-free DNA (cfDNA) analysis in maternal blood to detect common trisomies linked to genetic disorders. (Logo: http://photos.prnewswire.com/prnh/20120109/NY31734LOGO ) "The name perfectly describes Aria's goal of bringing harmony to patients,...
US is Global Leader in Creating Jobs, Income, Says Report WASHINGTON, Jan. 23, 2012 /PRNewswire-USNewswire/ -- A new Battelle report shows genetic and genomic testing is having a major impact on the economy -- creating 116,000 jobs and $16.5 billion in annual economic output -- and that sustained US leadership in this sector could provide "significant future economic and societal benefits." "Job creation is critical to improving the state of the union--and this industry is doing...
SAN JOSE, Calif., Jan. 12, 2012 /PRNewswire/ -- Aria Diagnostics, a molecular diagnostics company, announced that it is initiating a blinded, multicenter clinical trial that compares its non-invasive prenatal test with the standard first-trimester screening test (serum screening and nuchal translucency ultrasound alone and in combination) to detect Trisomy 21, which is associated with Down syndrome. Aria's test, which is currently in development, uses a directed,...
BETHESDA, Md., Jan. 11, 2012 /PRNewswire-USNewswire/ -- Genetics, genomics, personalized medicine, genetic testing, exome sequencing, prenatal testing, cancer genetics...the world of medicine and healthcare is in the midst of previously unfathomable changes and these topics are just a few of the many that will be explored at the 2012 ACMG Annual Clinical Genetics Meeting at the Charlotte, NC Convention Center, March 27-31. The ACMG Meeting is the genetics meeting most focused on the...
A new study has found that when parents get tested for breast cancer genes, many of them share their results with their children, even with those who are very young. Published early online in CANCER, a peer-reviewed journal of the American Cancer Society, the study also revealed that most parents think that their children are not distressed when they learn about the test results. For parents, one of the primary motivations for getting tested for hereditary cancer genes is to better...
